Publication | Closed Access

N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial

N-acetyl CysteinePsychiatryAddictionMedicinePhase IiiPsychotropic MedicationPsychopharmacologyNeuropharmacologyPlacebo-controlled TrialSocial SciencesCompulsive BehaviorPharmacologyPsychopathology